D-1050-2018 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

Recall Details

Product Type
Drugs
Report Date
August 8, 2018
Initiation Date
July 26, 2018
Termination Date
December 6, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,896 bottles

Product Description

Moxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-422-01

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.

Distribution Pattern

Product was distributed throughout the United States

Code Information

Lot #: H800393, Exp. 01/2020